---
title: "BIOCAUSE HEILEN PHARMA: Febuxostat tablets have obtained a drug registration certificate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/261999283.md"
description: "According to the Zhitong Finance APP, BIOCAUSE HEILEN PHARMA announced that the company recently received the \"Drug Registration Certificate\" approved and issued by the National Medical Products Administration, for the drug Febuxostat Tablets. Febuxostat Tablets are a xanthine oxidase inhibitor, primarily used for the long-term treatment of hyperuricemia and gout patients (including urate-lowering treatment after acute attacks of gouty arthritis)"
datetime: "2025-10-21T07:59:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/261999283.md)
  - [en](https://longbridge.com/en/news/261999283.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/261999283.md)
generator: "portal-rs"
---

# BIOCAUSE HEILEN PHARMA: Febuxostat tablets have obtained a drug registration certificate

According to the Zhitong Finance APP, BIOCAUSE HEILEN PHARMA (301211.SZ) announced that the company recently received the "Drug Registration Certificate" approved and issued by the National Medical Products Administration. The related drug is Febuxostat Tablets. Febuxostat Tablets are a xanthine oxidase inhibitor, mainly used for the long-term treatment of hyperuricemia and gout patients (including urate-lowering treatment after acute attacks of gouty arthritis)

### Related Stocks

- [301211.CN](https://longbridge.com/en/quote/301211.CN.md)

## Related News & Research

- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [CSPC Innovation Pharmaceutical: Biopharma licensing and product launches drove record revenue and profit growth](https://longbridge.com/en/news/296129143.md)
- [SandboxAQ introduces AQPotency for virtual drug screening](https://longbridge.com/en/news/296467103.md)
- [FONDIA: Profitability improved sharply in H1 2026, driven by growth in Finland and the Baltics](https://longbridge.com/en/news/296439068.md)
- [Butler National Wins Three-Year Extension to Manage Kansas Sports Wagering, Retains 90% Revenue Share](https://longbridge.com/en/news/296516585.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**